The US Neurovascular Intervention Market is expected to grow at an average annual growth rate of 6% over the next five years with thrombectomy devices, aneurysm stents and flow diversion devices offering above average growth.
The addition of carotid stent systems to within the neurovascular boundaries coupled with continued consolidation in the space have transformed the strategic landscape of the market which is expected to continue to offer lucrative acquisition opportunities to leading participants and high valuations to innovative startups.
The US Neurovascular Intervention Market Report segments the market into an endovascular aneurysm repair segment and a cerebral ischemia segment and analyzes leading device categories including embolic coils, intracranial aneurysm stents and flow diversion devices, liquid embolics, thrombectomy devices, intracranial ischemia stents as well as carotid stents and embolic protection devices.
US Neurovascular Intervention Market Report is targeted at senior executives in the medical device industry who wish to get up-to-date with this fast evolving field. It offers three linear forecast scenarios to 2020, and assesses product portfolios at leading companies in the space.
The report examines recent acquisitions in the space together with their implications on leading companies market shares and neurovascular startup valuation and prospects. Leading companies profiled include Stryker, Covidien, Codman Neurovascular (Johnson & Johnson), Abbott Vascular and MicroVention (Terumo). Other companies mentioned include Boston Scientific, Cerus Endovascular, MindFrame, NeuroVasx, Nfocus Neuromedical, Penumbra, Reverse Medical, Valor Medical.
Published: September 2013 - Number of Pages: #18 Pages - PDF by eMail
Table of Contents
1. Global Neurovascular Intervention Market
2. US Neurovascular Intervention Market
3. Leading Companies & Their Products
4. Recent Acquisitions in the Neurovascular Space
5. Leading Companies Market Shares
6. US Endovascular Cerebral Aneurysm Repair Market
6.1 US Neurovascular Embolic Coils Market
6.2 US Aneurysm Stents & Flow Diversion Devices Market
6.3 US Neurovascular Liquid Embolics Market
7. US Ischemic Stroke Market
7.1 US Cerebral Ischemia & Carotid Stents Market
7.2 US Neurovascular Thrombectomy Device Market
8. US Neurovascular Intervention Market Forecast
Tables & Figures
1. Global Neurovascular Intervention Sales & Growth Rates (2008 – 2013)
2. US Neurovascular Intervention Sales & Growth Rates (2008 – 2013)
3. US Neurovascular Intervention – Device Category Segmentation (2013)
4. US Neurovascular Intervention – Disease Area Segmentation (2013)
5. US Endovascular Cerebral Aneurysm Repair (ECAR) 2008 – 2013
6. US Endovascular Cerebral Aneurysm Repair – Device Segments (2013)
7. US Cerebral Ischemia Market Revenue & Growth Rates (2008 – 2013)
8. US Cerebral Ischemia Device Segmentats (2013)
9. US Neurovascular Intervention Market Forecast (2014 – 2020)
The addition of carotid stent systems to within the neurovascular boundaries coupled with continued consolidation in the space have transformed the strategic landscape of the market which is expected to continue to offer lucrative acquisition opportunities to leading participants and high valuations to innovative startups.
The US Neurovascular Intervention Market Report segments the market into an endovascular aneurysm repair segment and a cerebral ischemia segment and analyzes leading device categories including embolic coils, intracranial aneurysm stents and flow diversion devices, liquid embolics, thrombectomy devices, intracranial ischemia stents as well as carotid stents and embolic protection devices.
US Neurovascular Intervention Market Report is targeted at senior executives in the medical device industry who wish to get up-to-date with this fast evolving field. It offers three linear forecast scenarios to 2020, and assesses product portfolios at leading companies in the space.
The report examines recent acquisitions in the space together with their implications on leading companies market shares and neurovascular startup valuation and prospects. Leading companies profiled include Stryker, Covidien, Codman Neurovascular (Johnson & Johnson), Abbott Vascular and MicroVention (Terumo). Other companies mentioned include Boston Scientific, Cerus Endovascular, MindFrame, NeuroVasx, Nfocus Neuromedical, Penumbra, Reverse Medical, Valor Medical.
Published: September 2013 - Number of Pages: #18 Pages - PDF by eMail
Table of Contents
1. Global Neurovascular Intervention Market
2. US Neurovascular Intervention Market
3. Leading Companies & Their Products
4. Recent Acquisitions in the Neurovascular Space
5. Leading Companies Market Shares
6. US Endovascular Cerebral Aneurysm Repair Market
6.1 US Neurovascular Embolic Coils Market
6.2 US Aneurysm Stents & Flow Diversion Devices Market
6.3 US Neurovascular Liquid Embolics Market
7. US Ischemic Stroke Market
7.1 US Cerebral Ischemia & Carotid Stents Market
7.2 US Neurovascular Thrombectomy Device Market
8. US Neurovascular Intervention Market Forecast
Tables & Figures
1. Global Neurovascular Intervention Sales & Growth Rates (2008 – 2013)
2. US Neurovascular Intervention Sales & Growth Rates (2008 – 2013)
3. US Neurovascular Intervention – Device Category Segmentation (2013)
4. US Neurovascular Intervention – Disease Area Segmentation (2013)
5. US Endovascular Cerebral Aneurysm Repair (ECAR) 2008 – 2013
6. US Endovascular Cerebral Aneurysm Repair – Device Segments (2013)
7. US Cerebral Ischemia Market Revenue & Growth Rates (2008 – 2013)
8. US Cerebral Ischemia Device Segmentats (2013)
9. US Neurovascular Intervention Market Forecast (2014 – 2020)